基本信息
views: 86
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Li’s research is mainly focused on the development of lipid- and polymer-based nanodelivery systems for targeted delivery of various types of therapeutics including nucleic acids (genes, siRNA, and peptide nucleic acids), proteins, and small molecules (e.g., anticancer agents and antioxidants). Emphases are placed on the development of strategies to overcome cellular and in vivo barriers. Another research project in Dr. Li’s group is farnesoid X receptor (FXR)-mediated gene regulation in vascular cells and hepatic stellate cells. Research in Dr. Li’s lab has been continuously supported by grants from NIH and other funding agencies.
Research Interests
Papers共 259 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in immunology (2024): 1422113-1422113
JOURNAL OF CONTROLLED RELEASE (2024): 479-489
NATURE COMMUNICATIONSno. 1 (2024): 3178-3178
Zhangyi Luo,Yixian Huang,Neelu Batra,Yuang Chen,Haozhe Huang, Yifei Wang,Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang,Jingjing Sun,Qiming Jane Wang,
Nature communicationsno. 1 (2024): 255-255
Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 19 (2024): e2307940-e2307940
The Journal of biological chemistryno. 3 (2023): 103026-103026
Cancer letters (2023): 216396-216396
Biochemical pharmacology (2023): 115564-115564
Journal of nanobiotechnologyno. 1 (2023): 1-12
openalex(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn